Skip to main content
Livermore
Livermore
ZHEN

Woodline Partners LP

SEC CIK
0001784547
Latest filing
Aug 14, 2026

The latest 13F from Woodline Partners LP covers Q2 2026 (filed Aug 14, 2026): 1,011 long positions worth $32.4B. The top 10 holdings make up 17.2% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 3.3%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
166
Est. +$2.07B
Added
545
Est. +$7.35B
Reduced
214
Est. −$5.06B
Sold out
177
Est. −$2.57B

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    3.3%$1.08BHistory
  2. AAPLApple Inc.
    2.9%$927.5MHistory
  3. MSFTMicrosoft Corp
    1.9%$606.8MHistory
  4. AMZNAmazon Com Inc
    1.8%$588.4MHistory
  5. METAMeta Platforms, Inc.
    1.4%$463.3MHistory

Share of portfolio

Top 5 holdings and the other 1,006 positions, by share of portfolio value

  1. NVDA3.3%
  2. AAPL2.9%
  3. MSFT1.9%
  4. AMZN1.8%
  5. META1.4%
  6. Other 1,006 positions88.7%

Biggest buys

New and added positions, by estimated amount bought

  1. METAMeta Platforms, Inc.
    +$240.7MAddedHistory
  2. MCHPMicrochip Technology Inc
    +$209.1MAddedHistory
  3. LITELumentum Holdings Inc.
    +$177.3MAddedHistory
  4. PMPhilip Morris International Inc.
    +$160.2MAddedHistory
  5. CBChubb Ltd
    +$160.1MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MCHPMicrochip Technology Inc
    +0.66 pp0.1% → 0.7%History
  2. METAMeta Platforms, Inc.
    +0.58 pp0.9% → 1.4%History
  3. LITELumentum Holdings Inc.
    +0.55 pp<0.1% → 0.6%History
  4. CBChubb Ltd
    +0.49 pp<0.1% → 0.5%History
  5. PMPhilip Morris International Inc.
    +0.47 pp0.2% → 0.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. AMATApplied Materials Inc
    −$258.4MReducedHistory
  2. TXNTexas Instruments Inc
    −$231.0MReducedHistory
  3. DDOGDatadog, Inc.
    −$168.9MReducedHistory
  4. STXSeagate Technology Holdings plc
    −$147.4MReducedHistory
  5. TNGXTango Therapeutics, Inc.
    −$125.0MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. JNJJohnson & Johnson
    −0.59 pp1.4% → 0.8%History
  2. TXNTexas Instruments Inc
    −0.53 pp0.7% → 0.2%History
  3. SSRMSSR Mining Inc.
    −0.39 pp0.4% → 0.0%History
  4. LINLinde PLC
    −0.34 pp0.4% → 0.1%History
  5. VSHVishay Intertechnology Inc
    −0.34 pp0.3% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$32.4B
+$5.91B (+22.3%) vs. prior quarter
Positions
1,011
−11 vs. prior quarter
Top 10 concentration
17.2%
Top 10 as share of value
Turnover
25.9%
Q2 2026, one quarter
Average holding period
8.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $32.4B (Q2 2026)

Q1 2021: $4.51BQ2 2021: $5.36BQ3 2021: $6.04BQ4 2021: $6.82BQ1 2022: $6.02BQ2 2022: $6.12BQ3 2022: $6.81BQ4 2022: $7.25BQ1 2023: $7.08BQ2 2023: $8.41BQ3 2023: $8.53BQ4 2023: $9.17BQ1 2024: $10.8BQ2 2024: $10.4BQ3 2024: $11.8BQ4 2024: $14.8BQ1 2025: $15.4BQ2 2025: $18.9BQ3 2025: $21.2BQ4 2025: $25.8BQ1 2026: $26.4BQ2 2026: $32.4B
Q1 2021Q2 2026
13F filings of Woodline Partners LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 20261,011$32.4BNVDAAAPLMSFTvs. Q1 2026SEC
Q1 2026May 15, 2026Amended1,022$26.4BNVDAAAPLAMZNvs. Q4 2025SEC
Q4 2025Feb 17, 20261,010$25.8BiShares Core S&P 500 ETFNVDAAAPLvs. Q3 2025SEC
Q3 2025Nov 14, 2025870$21.2BMSFTNVDAAAPLvs. Q2 2025SEC
Q2 2025Aug 14, 2025911$18.9BMSFTMETANVDAvs. Q1 2025SEC
Q1 2025May 15, 2025891$15.4BMETAAAPLMSFTvs. Q4 2024SEC
Q4 2024Feb 14, 2025916$14.8BMETAAAPLNVDAvs. Q3 2024SEC
Q3 2024Nov 14, 2024584$11.8BMETAGILDABBVvs. Q2 2024SEC
Q2 2024Aug 14, 2024542$10.4BLLYREGNOVVvs. Q1 2024SEC
Q1 2024May 15, 2024525$10.8BLLYTELREGNvs. Q4 2023SEC
Q4 2023Feb 14, 2024464$9.17BABBVLLYREGNvs. Q3 2023SEC
Q3 2023Nov 14, 2023580$8.53BATVIABBVADIvs. Q2 2023SEC
Q2 2023Aug 14, 2023615$8.41BASMLATVIJNJvs. Q1 2023SEC
Q1 2023May 15, 2023618$7.08BAPHREGNKEYSvs. Q4 2022SEC
Q4 2022Feb 14, 2023742$7.25BTELBKNGLHXvs. Q3 2022SEC
Q3 2022Nov 14, 2022741$6.81BHZNPGILDREGNvs. Q2 2022SEC
Q2 2022Aug 15, 2022791$6.12BLLYSTMSWKSvs. Q1 2022SEC
Q1 2022May 16, 2022708$6.02BSGENCOOZNGAvs. Q4 2021SEC
Q4 2021Feb 14, 2022693$6.82BQRVOABBVASMLvs. Q3 2021SEC
Q3 2021Nov 15, 2021671$6.04BTERJNJHZNPvs. Q2 2021SEC
Q2 2021Aug 16, 2021586$5.36BJNJAPHTXNvs. Q1 2021SEC
Q1 2021May 17, 2021427$4.51BJNJAPHGILD–SEC

13D and 13G filings

Companies where Woodline Partners LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

9 companies, largest stake first.

Companies where Woodline Partners LP owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
AIROAIRO Group Holdings, Inc.13G/A8.50%2.75M shares+1.30 ppfrom 7.20%Aug 14, 20252 filingsNov 14, 2025SEC
ZVRAZevra Therapeutics, Inc.13G/A8.10%4.79M shares+1.90 ppfrom 6.20%Nov 14, 20243 filingsAug 14, 2026SEC
CALCCalciMedica, Inc.13G8.10%2.49M sharesNewAug 14, 20261 filingAug 14, 2026SEC
OKYOOKYO Pharma Ltd13G7.00%3.65M sharesNewMay 15, 20261 filingMay 15, 2026SEC
SABSSAB Biotherapeutics, Inc.13G/A6.80%5.46M shares−3.10 ppfrom 9.90%Nov 14, 20252 filingsAug 14, 2026SEC
EQEquillium, Inc.13G5.90%3.51M sharesNewNov 14, 20251 filingNov 14, 2025SEC
XOMAXOMA Royalty Corp13G5.40%640.0K sharesNewMay 15, 20261 filingMay 15, 2026SEC
BHVNBiohaven Ltd.13G5.10%7.66M sharesNewAug 14, 20261 filingAug 14, 2026SEC
CRVOCervoMed Inc.13G5.10%689.0K sharesNewAug 14, 20261 filingAug 14, 2026SEC

Latest filings

61 filings on file made by Woodline Partners LP or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Woodline Partners LP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
ZVRAZevra Therapeutics, Inc.Aug 14, 202611:06 AM ET13G/A8.10%4.79M shares+1.90 ppfrom 6.20%Jun 30, 2026SEC
TNGXTango Therapeutics, Inc.Aug 14, 202611:05 AM ET13G/A2.50%4.00M shares−3.10 ppfrom 5.60%Below 5%Jun 30, 2026SEC
SABSSAB Biotherapeutics, Inc.Aug 14, 202611:04 AM ET13G/A6.80%5.46M shares−3.10 ppfrom 9.90%Jun 30, 2026SEC
CRVOCervoMed Inc.Aug 14, 202611:03 AM ET13G5.10%689.0K sharesNewJun 30, 2026SEC
CALCCalciMedica, Inc.Aug 14, 202611:02 AM ET13G8.10%2.49M sharesNewJun 30, 2026SEC
BRCBBlack Rock Coffee Bar, Inc.Aug 14, 202611:00 AM ET13G/A0.00%0 shares−5.50 ppfrom 5.50%Below 5%Jun 30, 2026SEC
BHVNBiohaven Ltd.Aug 14, 202611:00 AM ET13G5.10%7.66M sharesNewJun 30, 2026SEC
TNGXTango Therapeutics, Inc.May 15, 20269:16 AM ET13G/A5.60%8.00M shares−1.90 ppfrom 7.50%Mar 31, 2026SEC
BJRIBJs RESTAURANTS INCMay 15, 20269:14 AM ET13G/A4.60%983.3K shares−0.40 ppfrom 5.00%Below 5%Mar 31, 2026SEC
QNRXQuoin Pharmaceuticals Ltd.May 15, 20269:13 AM ET13G/A4.40%2.79M shares−5.10 ppfrom 9.50%Below 5%Mar 31, 2026SEC
ACETAdicet Bio, Inc.May 15, 20269:11 AM ET13G/A3.30%313.1K shares−3.20 ppfrom 6.50%Below 5%Mar 31, 2026SEC
VSHVishay Intertechnology IncMay 15, 20269:08 AM ET13G/A4.00%4.95M shares−4.20 ppfrom 8.20%Below 5%Mar 31, 2026SEC
OMOutset Medical, Inc.May 15, 20269:06 AM ET13G/A1.60%292.4K shares−5.90 ppfrom 7.50%Below 5%Mar 31, 2026SEC
ALGSAligos Therapeutics, Inc.May 15, 20269:05 AM ET13G/A4.40%239.4K shares−1.00 ppfrom 5.40%Below 5%Mar 31, 2026SEC
XOMAXOMA Royalty CorpMay 15, 20269:03 AM ET13G5.40%640.0K sharesNewMar 31, 2026SEC
BRCBBlack Rock Coffee Bar, Inc.May 15, 20269:02 AM ET13G5.50%955.8K sharesNewMar 31, 2026SEC
OKYOOKYO Pharma LtdMay 15, 20269:01 AM ET13G7.00%3.65M sharesNewMar 31, 2026SEC
TNGXTango Therapeutics, Inc.Feb 17, 20263:22 PM ET13G/A7.50%10.1M shares+1.90 ppfrom 5.60%Dec 31, 2025SEC
ALGSAligos Therapeutics, Inc.Feb 17, 20263:22 PM ET13G/A5.40%289.2K shares−3.30 ppfrom 8.70%Dec 31, 2025SEC
PLRXPliant Therapeutics, Inc.Feb 17, 20263:21 PM ET13G/A3.30%2.03M shares−4.00 ppfrom 7.30%Below 5%Dec 31, 2025SEC